| Name | ML-179 | 
|---|---|
| Synonyms | 2,4(1H,3H)-Pyrimidinedione, 3-cyclohexyl-6-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]- 3-Cyclohexyl-6-{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}-2,4(1H,3H)-pyrimidinedione 3-cyclohexyl-6-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]-1H-pyrimidine-2,4-dione ML-179 | 
| Description | ML179 (SR-1309) is a inverse LRH1 (Liver receptor homologue-1) agonist with IC50 of 320 nM. ML179 shows anti-proliferation activity in MDA-MB-231 cells. ML179 has the potential for the research of ER-negative breast cancer[1]. | 
|---|---|
| Related Catalog | |
| Target | LRH-1[1] | 
| References | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Molecular Formula | C21H25F3N4O2 | 
| Molecular Weight | 422.44 | 
| Exact Mass | 422.192963 | 
| LogP | 4.80 | 
| Index of Refraction | 1.568 |